Adamis Pharmaceuticals Corporation recalls SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only,…

Recall date

March 21, 2022

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0764-2022

FDA classification

Class I

Brand / firm

Adamis Pharmaceuticals Corporation

Sold / distributed

Nationwide in the U.S.A.

Why it was recalled

Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.

Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.

What was recalled

SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.